Diagnostics for SARS-CoV-2 infections

@article{Kevadiya2021DiagnosticsFS,
  title={Diagnostics for SARS-CoV-2 infections},
  author={Bhavesh D. Kevadiya and Jatin Machhi and Jonathan Herskovitz and Maxim D. Oleynikov and Wilson R. Blomberg and Neha Bajwa and Dhruvkumar Soni and Srijanee Das and Mahmudul Hasan and Milankumar Patel and Ahmed M. Senan and Santhi Gorantla and JoEllyn McMillan and Benson J. Edagwa and Robert Eisenberg and Channabasavaiah B. Gurumurthy and St. Patrick Reid and Chamindie Punyadeera and Linda Chang and Howard E. Gendelman},
  journal={Nature Materials},
  year={2021},
  volume={20},
  pages={593 - 605}
}
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to nearly every corner of the globe, causing societal instability. The resultant coronavirus disease 2019 (COVID-19) leads to fever, sore throat, cough, chest and muscle pain, dyspnoea, confusion, anosmia, ageusia and headache. These can progress to life-threatening respiratory insufficiency, also affecting the heart, kidney, liver and nervous systems. The diagnosis of SARS-CoV-2 infection is often confused with that of… 
Biochemical composition, transmission and diagnosis of SARS-CoV-2
TLDR
This review provides an updated overview of various techniques of COVID-19 testing in human samples and also discusses, in brief, the biochemical composition and mode of transmission of the SARS-CoV-2.
Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms
TLDR
In conclusion, the insights of this review would facilitate the development of more likely diagnostics and ideal vaccines for the global control of COVID-19.
COVID-19 Pandemic: Advances in Diagnosis, Treatment, Organoid Applications and Impacts on Cancer Patient Management
TLDR
The importance of organoid technology as a valuable experimental virology platform to better understand the pathogenesis of CO VID-19 and assist rapid screening of drugs against COVID-19 is emphasized.
Molecular Virology of SARS-CoV-2 and Related Coronaviruses
TLDR
The molecular mechanisms of Sars-CoV-2 and related coronaviruses are discussed, focusing on the host factors or pathways involved in SARS-Cov-2 replication that have been identified by genome-wide CRISPR screening.
Rapid diagnostic methods for SARS-CoV-2 (COVID-19) detection: an evidence-based report
TLDR
A potential discovery that could lead to the mass and targeted SARS-CoV-2 detection needed to manage the COVID-19 pandemic through infection succession and timely therapy is discussed.
Detection and Differentiation of SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses by CRISPR
TLDR
The validation of the test in nasopharyngeal specimens showed that it had a 90–100% sensitivity and 100% specificity for the detection of SARS-CoV-2, influenza A and B, and RSV.
Circulation of Non-SARS-CoV-2 Respiratory Pathogens and Coinfection with SARS-CoV-2 Amid the COVID-19 Pandemic
TLDR
The COVID-19 pandemic impacted the circulation of certain respiratory pathogens and other respiratory viral pathogens were associated with symptomatic infections; however, coinfections with SARS-CoV-2 were highly uncommon.
Review of Current COVID-19 Diagnostics and Opportunities for Further Development
TLDR
A comprehensive review of currently available COVID-19 diagnostics is provided, exploring their pros and cons as well as appropriate indications.
Animal Coronavirus Diseases: Parallels with COVID-19 in Humans
TLDR
An overview of coronaviruses, clinical signs, COVID-19 in animals, genome organization and recombination, immunopathogenesis, transmission, viral shedding, diagnosis, treatment, and prevention, providing a critical basis for the development of effective vaccines and therapeutics against these deadly viruses.
Mass Spectrometry Approaches for SARS-CoV-2 Detection: Harnessing for Application in Food and Environmental Samples
TLDR
This review covers the most relevant established methods for MS-based SARS-CoV-2 detection and discusses the future application of these tools in different matrices.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 147 REFERENCES
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
TLDR
Intense global efforts have targeted research into a better understanding of the epidemiology, molecular biology, pharmacology, and pathobiology of SARS-CoV-2 to provide the insights directed to curtailing this disease outbreak with intense international impact.
Current approaches in laboratory testing for SARS-CoV-2
Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
TLDR
The challenges faced in developing a diagnostic test for a novel pathogen are the ability to measure low viral loads for early detection, to provide low or no cross-reactivity with other viral strains and to deliver results rapidly.
CRISPR-Cas12–based detection of SARS-CoV-2
TLDR
The CRISPR-based DETECTR assay provides a visual and faster alternative to the US Centers for Disease Control and Prevention SARS-CoV-2 real-time RT–PCR assay, with 95% positive predictive agreement and 100% negative predictive agreement.
Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients With Coronavirus Disease 2019
TLDR
SARS-CoV-2 evolves in vivo after infection, which may affect its virulence, infectivity, and transmissibility, and it is necessary to strengthen the surveillance of the viral evolution in the population and associated clinical changes.
Rapid Detection of IgM Antibodies against the SARS-CoV-2 Virus via Colloidal Gold Nanoparticle-Based Lateral-Flow Assay
TLDR
A colloidal gold nanoparticle-based lateral-flow assay was developed and showed outstanding selectivity in the detection of IgM against the SARS-CoV-2 virus with no interference from other viruses such as severe fever with thrombocytopenia syndrome virus (SFTSV) and dengue virus (DFV).
A novel strategy for community screening of SARS-CoV-2 (COVID-19): Sample pooling method
TLDR
The feasibility of using a pooled testing strategy to increase testing capacity and conserve resources, especially when there is a high demand for disease testing is demonstrated.
Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients
TLDR
It is demonstrated that most PCR-confirmed SARS-CoV-2–infected persons seroconverted by 2 weeks after disease onset, and validated and tested various antigens in different in-house and commercial ELISAs, finding that commercial S1 IgG or IgA ELISA were of lower specificity, and sensitivity varied between the 2 assays; the IgAELISA showed higher sensitivity.
Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome.
TLDR
The review of experiences with the MERS and SARS outbreaks will help the role of the radiologist in combating the outbreak of COVID-19 and the known imaging manifestations of the novel coronavirus and the possible unknowns will be discussed.
...
1
2
3
4
5
...